Sangamo Therapeutics
SGMO
#8837
Rank
HK$1.16 B
Marketcap
HK$3.47
Share price
3.81%
Change (1 day)
-80.65%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: HK$1.16 Billion

As of December 2025 Sangamo Therapeutics has a market cap of HK$1.16 Billion. This makes Sangamo Therapeutics the world's 8837th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$1.16 B-71.82%
2024HK$4.14 B451.05%
2023HK$0.75 B-81.28%
2022HK$4.02 B-52.81%
2021HK$8.51 B-50.21%
2020HK$17.11 B126.33%
2019HK$7.55 B-17.71%
2018HK$9.18 B-15.17%
2017HK$10.82 B548.36%
2016HK$1.67 B-66.45%
2015HK$4.97 B-38.9%
2014HK$8.14 B21.53%
2013HK$6.70 B171.24%
2012HK$2.47 B113.55%
2011HK$1.15 B-50.64%
2010HK$2.34 B13.53%
2009HK$2.06 B87.42%
2008HK$1.10 B-73.08%
2007HK$4.09 B127.53%
2006HK$1.79 B88.33%
2005HK$0.95 B-18.93%
2004HK$1.17 B11.37%
2003HK$1.05 B82.18%
2002HK$0.58 B-67.43%
2001HK$1.78 B-47.07%
2000HK$3.36 B

End of Day market cap according to different sources

On Dec 18th, 2025 the market cap of Sangamo Therapeutics was reported to be:

HK$1.12 Billion
by Nasdaq info icon info icon
HK$1.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
HK$1.199 T 102,568.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$411.40 B 35,101.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.371 T 117,260.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$199.52 B 16,971.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
HK$128.63 B 10,906.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$3.868 T 330,904.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$91.40 B 7,720.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$1.964 T 167,997.33%๐Ÿ‡บ๐Ÿ‡ธ USA